These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2737612)
1. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Hall PA; Donaghy M; Cotter FE; Stansfeld AG; Levison DA Histopathology; 1989 Apr; 14(4):333-46; discussion 429-32. PubMed ID: 2737612 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type. Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184 [TBL] [Abstract][Full Text] [Related]
3. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Radaszkiewicz T; Hansmann ML; Lennert K Histopathology; 1989 Jan; 14(1):11-24. PubMed ID: 2925176 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606 [TBL] [Abstract][Full Text] [Related]
5. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: a case report with immunohistochemical study]. Dworák O; Tschubel K; Zhou H; Meybehm M Klin Wochenschr; 1988 Jul; 66(13):591-5. PubMed ID: 3210655 [TBL] [Abstract][Full Text] [Related]
6. Plasma cell variant of Castleman's disease localized to the liver: a case report. Mosnier JF; Fléjou JF; Degos F; Belghiti J; Brouet JC; Benhamou JP; Degott C Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):169-72. PubMed ID: 8723423 [TBL] [Abstract][Full Text] [Related]
7. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Amin HM; Medeiros LJ; Manning JT; Jones D Am J Surg Pathol; 2003 Jan; 27(1):91-100. PubMed ID: 12502931 [TBL] [Abstract][Full Text] [Related]
8. Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report. Gould SJ; Diss T; Isaacson PG Histopathology; 1990 Aug; 17(2):135-40. PubMed ID: 2227838 [TBL] [Abstract][Full Text] [Related]
9. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Danon AD; Krishnan J; Frizzera G Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):369-82. PubMed ID: 8116226 [TBL] [Abstract][Full Text] [Related]
10. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype. Harris NL; Bhan AK Am J Surg Pathol; 1987 Feb; 11(2):109-13. PubMed ID: 3544885 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Nishi J; Maruyama I Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746 [TBL] [Abstract][Full Text] [Related]
12. Reactive lymphoid hyperplasia of the liver characterized by an angiofollicular pattern mimicking Castleman's disease. Tanizawa T; Eishi Y; Kamiyama R; Nakahara M; Abo Y; Sumita T; Kawano N Pathol Int; 1996 Oct; 46(10):782-6. PubMed ID: 8916149 [TBL] [Abstract][Full Text] [Related]
13. Pathohistological and immunohistochemical studies on Castleman's disease of the lymph node. Nagai K; Sato I; Shimoyama N Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):287-97. PubMed ID: 3087057 [TBL] [Abstract][Full Text] [Related]
14. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957 [TBL] [Abstract][Full Text] [Related]
15. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease. Peh SC; Shaminie J; Poppema S; Kim LH Singapore Med J; 2003 Apr; 44(4):185-91. PubMed ID: 12952030 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous castleman's disease responds to anti interleukin-6 treatment. Ahmed B; Tschen JA; Cohen PR; Zaki MH; Rady PL; Tyring SK; Corringham RE; Kurzrock R Mol Cancer Ther; 2007 Sep; 6(9):2386-90. PubMed ID: 17766835 [TBL] [Abstract][Full Text] [Related]
17. Castleman's disease associated with pemphigus vulgaris. Gili A; Ngan BY; Lester R J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):955-9. PubMed ID: 1761779 [TBL] [Abstract][Full Text] [Related]
18. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293 [TBL] [Abstract][Full Text] [Related]
19. Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings. Massey GV; Kornstein MJ; Wahl D; Huang XL; McCrady CW; Carchman RA Cancer; 1991 Sep; 68(6):1365-72. PubMed ID: 1873789 [TBL] [Abstract][Full Text] [Related]
20. Angiofollicular lymph node hyperplasia (Castleman's disease): an immunohistochemical and enzyme-histochemical study of the hyaline-vascular form of lesion. Jones EL; Crocker J; Gregory J; Guibarra M; Curran RC J Pathol; 1984 Oct; 144(2):131-47. PubMed ID: 6092594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]